 GenMark Diagnostics, Inc. GNMK, a leading provider of automated, multiplex molecular diagnostic testing systems, has been selected by Vidant Health as its primary provider of rapid diagnostic testing. Vidant is deploying GenMarks ePlex system across all nine of its hospitals to test for SARS-CoV-2 and other respiratory pathogens, as well as blood stream infections. The largest health system in eastern North Carolina, Vidant Health, is using GenMarks ePlex SARS-CoV-2 Test one of the first rapid diagnostic tests for the virus that causes COVID-19 and will transition to the ePlex Respiratory Pathogen 2 RP2 Panel once GenMark has submitted the application for Emergency Use Authorization EUA to the U.S. Food and Drug Administration FDA. 